Rhenman & Partners Asset Management AB - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$516,000
-23.6%
1,200,0000.0%0.09%
-31.3%
Q1 2016$675,000
-67.0%
1,200,000
+0.9%
0.13%
-56.6%
Q4 2015$2,045,000
-18.5%
1,189,0000.0%0.31%
-22.8%
Q3 2015$2,509,000
-35.8%
1,189,000
+50.7%
0.40%
-14.7%
Q2 2015$3,906,000
-40.0%
789,000
-5.1%
0.47%
-57.3%
Q1 2015$6,513,000
+186.5%
831,800
+121.8%
1.10%
+66.6%
Q4 2014$2,273,000
+8.0%
375,000
-24.1%
0.66%
+7.0%
Q3 2014$2,104,000
+13.4%
494,000
+64.6%
0.62%
+12.0%
Q2 2014$1,855,000
-13.3%
300,199
-8.8%
0.55%
-14.3%
Q1 2014$2,140,000
+52.0%
329,199
+31.7%
0.64%
+16.5%
Q4 2013$1,408,000250,0000.55%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders